The insurer plans to sell its Medicare prescription-drug business to WellCare Health Plans.

The newly acquired health marketing agency uses data and analytics to help clients navigate payer behavior and the reimbursement environment.

Deals of all sizes, including XL Catlin and AXA, are informed by a the need to transform operating models across the sector.

After almost a decade of deals that have been lauded by the market, Broadcom's Tan has some explaining to do about his latest target.

Many also believe the CVS-Aetna and Cigna-Express Scripts deals have a greater chance of success after a judge gave a go-ahead to AT&T-Time Warner.

The insurance giant said it would need to make a “significant additional investment” to gain scale and be competitive. It has hired an investment banker to help it unload deposits and loans.

In a sign of its ambition, last month, CVS hired a senior executive from a startup that specializes in primary-care clinics to oversee expanded health-care services across the company.

Retailers are eyeing health insurers as acquisition targets to improve their pharmacy business, but carriers' information assets and analytics prowess are prizes as well.

While industry observers are excited by the prospect of additional data and tech innovation boosting the company, the reinsurer is cautious.

The health insurer’s rivals are striking deals to make them one-stop health superstores with insurance, drug coverage, pharmacies, clinics and doctors.

The proposed Walmart-Humana combination is the latest of a series of moves that point to an abrupt change in the industry.

Consolidation in the industry continues to accelerate, providing less competition, fewer options for consumers.

Insurers, drugstores, distributors and pharmacy benefit managers looking for partners.

Justice Department looks to assess proposed merger with Express Scripts, as well as CVS Health-Aetna combo.

The combination of insurers announced this week shows the importance of technology innovation to M&A strategy.

Across lines of business, insurers are looking to leverage their intellectual property to create more income streams.

Insurer acquiring the largest remaining independent drug middleman.

The israeli vendor will merge Adaptik's core offerings with its cloud-based analytics platform.

The German insurer is reportedly looking at XL as a potential target to grow its casualty coverage business in the U.S.

American International Group cites reinsurer's CAT modeling and analytics as reasons it's looking to make the acquisition.